PGK1 Antibodies

Santa Cruz Biotechnology features a diverse variety of PGK1 monoclonal antibodies for investigating phosphoglycerate kinase 1 (PGK1) in various biological processes. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PGK1 is a critical enzyme in the glycolytic pathway, catalyzing the conversion of 1,3-bisphosphoglycerate to 3-phosphoglycerate while generating ATP. Proper PGK1 function is essential for cellular energy metabolism, and its dysregulation has been implicated in various diseases, including cancer and metabolic disorders. Understanding PGK1's role can provide insights into cellular energy dynamics and potential therapeutic targets. Researchers can explore PGK1's expression patterns across different tissue types and cellular conditions. Advanced visualization techniques allow for detailed analysis of PGK1 localization and interactions within cellular compartments. Comprehensive characterization of PGK1 activity helps reveal its regulatory mechanisms and metabolic impact. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance their understanding of PGK1's role in health and disease progression.